Belikov, Aleksey V.
Talay, Angelo
de Magalhães, João Pedro
Funding for this research was provided by:
Biotechnology and Biological Sciences Research Council (BB/V010123/1)
Biotechnology and Biological Sciences Research Council (BB/V010123/1)
Article History
Received: 20 January 2025
Accepted: 29 April 2025
First Online: 19 May 2025
Competing interests
: J.P.M. is CSO of YouthBio Therapeutics, an advisor/consultant for the BOLD Longevity Growth Fund and NOVOS, and the founder of Magellan Science Ltd, a company providing consulting services in longevity science.